The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
Activity Number:
|
299
|
Type:
|
Contributed
|
Date/Time:
|
Tuesday, July 31, 2012 : 8:30 AM to 10:20 AM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #305295 |
Title:
|
Meta-Analysis of Rare Adverse Events in Randomized Controlled Clinical Trials: A Case Study
|
Author(s):
|
Eunhee Hwang*+ and Suna Barlas and Lingfeng Yang
|
Companies:
|
Pfizer Inc. and Pfizer Inc. and Pfizer Inc.
|
Address:
|
Mail Stop A4, Collegeville, PA, 19426, United States
|
Keywords:
|
Meta-analysis ;
Rare events ;
Case study ;
Continuity correction ;
Coverage probability ;
Binomial outcome
|
Abstract:
|
Meta-analysis of randomized controlled clinical trials are often used to evaluate the effect of a new drug entity on rare adverse events as safety characterization plays an important role in the overall benefit risk assessment. In this case study, we apply commonly used meta-analysis techniques to our clinical trial data: combining summary statistics across trials via variance inflation or Newcombe method, Bayesian fixed/random effect model, generalized linear model, and generalized linear mixed model. We examine the impact of explicit and implicit assumptions in each technique and provide intuitive interpretation for some surprising results. Our choice of analysis method and metrics for the data are explained considering the issue of continuity correction, large sample approximation, bias, coverage probability and the maximum use of all available data. In this presentation, we limit our
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.